BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2

Nature Genetics

Volumn 30, Issue 1, 2002, Pages 48-58

  Perrotti, Danilo ^a   Cesi, Vincenzo ^a   Trotta, Rossana ^a   Guerzoni, Clara ^b   Santilli, Giorgia ^a   Campbell, Kenneth ^a   Iervolino, Angela ^a   Condorelli, Fabrizio ^a   Gambacorti Passerini, Carlo ^c,d   Caligiuri, Michael A ^e,f   Calabretta, Bruno ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c NCI   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

^f Cancer and Leukemia Group B   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; HEMATOPOIETIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; STEM CELL; TRANSLATION REGULATION;

ANIMALS; APOPTOSIS; BLAST CRISIS; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MICE; MYELOID CELLS; NEOPLASM PROTEINS; OLIGODEOXYRIBONUCLEOTIDES; PIPERAZINES; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PYRIMIDINES; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR STEM CELLS;

ANIMALIA;

EID: 0036340784     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng791     Document Type: Article

References (50)

1. Chronic myelogenous leukemia: A concise update
2. Biological consequences of the BCR-ABL fusion gene in humans and mice
3. Chronic myeloid leukemia
4. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by BCR-ABL
5. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR-ABL-mediated leukemogenesis
6. Regulation of granulopoiesis by transcription factors and cytokine signals
7. Diversification of hematopoietic stem cells to specific lineages
8. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice
9. CCAAT enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors
10. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony- stimulating factor receptor promoter in myeloid cells
11. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts
12. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells
13. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells
14. Initiation of translation in prokaryotes and eukaryotes
15. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
16. Inhibition of CCAAT/enhancer-binding proteinα and β translation by upstream open reading frames
17. Expression of the chronic myelogenous leukemia-associated p210BCR-ABL oncoprotein in a murine IL-3 dependent myeloid cell line
18. Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells
19. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid
20. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein α message: Transcriptional activator lacking antimitotic activity
21. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials
22. Translational control of C/EBPα and C/EBPβ isoforms expression
23. The role of the 5′ untranslated region of an mRNA in translation regulation during development
24. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first
25. Cytoplasmic regulatory functions of the KH-domain proteins hnRNP K and E1/E2
26. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase
27. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: Regulation of multiple myeloid CSF receptor promoters
28. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter
29. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression
30. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
31. Chronic myelogenous leukemia in blast crisis: Analysis of 242 patients
32. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner
33. Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7
34. AML-1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
35. v-Abl activates c-myc transcription through the E2F site
36. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway
37. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase Cβll-dependent pathway
38. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation
39. Translational pathophysiology: A novel molecular mechanism of human disease
40. Optimized RNA targets of two closely-related triple KH-domains proteins, hnRNP K and aCP-2KL, suggest distinct modes of RNA recognition
41. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end
42. Lipoxygenase mRNA silencing in erythroid differentiation: The 3′ UTR regulatory complex controls 605 ribosomal subunit joining
43. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogeneous ribonucleoprotein K and Poly(rC)-binding proteins 1 and 2
44. Requirement of poly(rC)-binding protein 2 for translation of poliovirus RNA
45. The N-terminal K homology domain of the poly(rC)-binding protein is a major determinant for binding to the poliovirus 5′ untranslated region and acts as an inhibitor of viral translation
46. Interaction of poly(rC)-binding protein 2 with the 5? Noncoding region of hepatitis A virus RNA and its effects on translation
47. Dominant-negative mutations of C/EBPα, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
48. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granulocytic differentiation
49. Optimized RNA gel-shift and UV crosslinking assays for characterization of cytoplasmic RNA-protein interactions
50. Two functional complexes formed by KH domain containing proteins with the 5′ noncoding region of poliovirus RNA